NSPHChart Suggesting Higher
Week of Nov 11, NSPH broke above its downtrend line on heavy volume.
11/21/13 bounce off the 20 day EMA a bullish sign.
MACD has made a bullish centerline crossover.
RSI has plenty of room at 49.
Target is gap resistance- about 2.95.
Received upgrade to "Buy" this week.
Closed Friday at 2.11, AH at 2.19.
Low PPS = aggressive play
https://stockcharts.com/h-sc/ui?s=NSPH
Catalysts in first and second quarters, 2014.
Coming off of a successful offering- enough to take through 2014.
Nanosphere (NSPH) is on the verge of garnering a big slice of the growing molecular diagnostic business with its rapid diagnostic tests of bacteria and expected soon, viruses.
Motly Fool players rate NSPH as follows:
All Players
149 Outperform
19 Underperform
All-Star Players
29 Outperform
10 Underperform
Wall Street
7 Outperform
0 Underperform
Fron NSPH 10Q:
"Nanosphere (NSPH) is enhancing medicine through targeted molecular diagnostics that result in earlier disease detection, optimal patient treatment and improved healthcare economics. The Company's versatile technology platform, the Verigene(R) System, enables clinicians to rapidly detect the most complex, costly and deadly infectious diseases through a low cost and simple-to-use multiplexed diagnostic test. The combination of this innovative technology and Nanosphere's customer-driven solutions keeps commitment to the patient at the forefront of its business. Nanosphere) is based in Northbrook, IL"